GZMB and acute myeloid leukemia: Similarly, TIM-3+ NK cells showed significantly higher GZMB levels than TIM-3− NK cells in both AML patients and HDs (p < 0.001 and =0.014, Figure 2E,F), and pairwise analysis showed consistent results (p < 0.001 and =0.016, Figure 2G).